Inrig Jula
SEC CIK 1902368 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | EVP, CMO, Head of R, D | 145.2K | — | $5.51M | 28 | 2022-01-01 | 2026-09-15 |
Most active insiders at TVTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dube Eric M | CEO, Dir | — | $41.35M |
| 2 | Heerma Peter | EVP, Chief COMMERCIAL Off | — | $18.97M |
| 3 | ROTE WILLIAM E. | Chief Research Off | — | $16.43M |
| 4 | REED ELIZABETH E | CLO, GC | — | $7.02M |
| 5 | Inrig Jula | EVP, CMO, Head of R, D | — | $5.16M |
| 6 | Cline Christopher R. | CFO | — | $4.64M |
| 7 | Calvin Sandra | SVP, CAO | — | $4.19M |
| 8 | Baynes Roy D. | Dir | — | $2.55M |
| 9 | Meckler Jeffrey A | Dir | — | $1.71M |
| 10 | Coughlin Timothy | Dir | — | $1.27M |
Transactions 28
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-17 21:33 | 2026-09-15 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | EVP, CMO, Head of R, D | M - OptEx | $8.93 | +32.4K | 145.2K | +29% | +$289.3K |
| DMT | 2026-09-17 21:33 | 2026-09-15 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | EVP, CMO, Head of R, D | S - Sale+OE | $62.34 | -44.7K | 100.5K | -31% | -$2.79M |
| 2026-06-22 16:37 | 2026-06-22 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | G - Gift | $0.00 | -468 | 112.8K | -0.4% | $0 | |
| DMT | 2026-05-06 20:00 | 2026-05-04 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | M - OptEx | $18.47 | +24.2K | 115.7K | +27% | +$448.0K |
| DMT | 2026-05-06 20:00 | 2026-05-04+ | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | S - Sale+OE | $45.15 | -22.5K | 113.2K | -17% | -$1.02M |
| T | 2026-04-15 21:46 | 2026-04-13 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | A - Grant | $0.00 | +14.0K | 119.7K | +13% | $0 |
| MT | 2026-04-15 21:46 | 2026-04-14+ | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | S - Sale | $42.01 | -8,233 | 111.5K | -7% | -$345.9K |
| M | 2026-02-05 | 2026-02-04 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | S - Sale | $32.21 | -1,779 | 105.9K | -2% | -$57.3K |
| D | 2026-02-03 | 2026-01-31 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | A - Grant | $0.00 | +28.1K | 114.4K | +33% | $0 |
| D | 2026-02-03 | 2026-02-03 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | S - Sale | $32.12 | -6,956 | 107.5K | -6% | -$223.4K |
| M | 2026-01-07 | 2026-01-05+ | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | S - Sale | $39.74 | -2,476 | 86.8K | -3% | -$98.4K |
| D | 2025-12-29 | 2025-12-24 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | S - Sale+OE | $42.00 | -15.0K | 88.8K | -14% | -$630.0K |
| D | 2025-12-29 | 2025-12-24 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | M - OptEx | $8.93 | +15.0K | 103.8K | +17% | +$133.9K |
| 2025-07-02 | 2025-07-01 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | S - Sale | $14.65 | -815 | 88.8K | -0.9% | -$11.9K | |
| D | 2025-02-12 | 2025-02-12 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | S - Sale+OE | $23.53 | -2,568 | 89.6K | -3% | -$60.4K |
| D | 2025-02-12 | 2025-02-10 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | M - OptEx | — | +8,000 | 92.2K | +10% | — |
| DM | 2025-02-04 | 2025-02-03+ | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | S - Sale | $20.12 | -5,273 | 84.2K | -6% | -$106.1K |
| D | 2025-02-04 | 2025-01-31 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | A - Grant | $0.00 | +30.0K | 89.4K | +50% | $0 |
| M | 2025-01-06 | 2025-01-03+ | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | S - Sale | $19.04 | -2,506 | 59.9K | -4% | -$47.7K |
| 2024-09-10 | 2024-09-10 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | S - Sale | $12.98 | -684 | 61.9K | -1% | -$8,878 | |
| 2024-09-09 | 2024-09-05 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | A - Grant | $0.00 | +6,750 | 64.8K | +12% | $0 | |
| 2024-09-09 | 2024-09-09 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | S - Sale | $11.52 | -2,191 | 62.6K | -3% | -$25.2K | |
| D | 2024-02-02 | 2024-01-31 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | A - Grant | $0.00 | +25.0K | 60.2K | +71% | $0 |
| D | 2024-02-02 | 2024-02-01 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief MEDICAL Off | S - Sale | $8.53 | -2,174 | 58.1K | -4% | -$18.5K |
| M | 2024-01-05 | 2024-01-03+ | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief Medical Off | S - Sale | $9.43 | -2,509 | 35.7K | -7% | -$23.6K |
| D | 2023-02-02 | 2023-01-31 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief Medical Off | A - Grant | $0.00 | +20.2K | 37.8K | +116% | $0 |
| M | 2023-01-06 | 2023-01-04+ | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief Medical Off | S - Sale | $20.75 | -2,493 | 17.9K | -12% | -$51.7K |
| D | 2022-01-04 | 2022-01-01 | TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief Medical Off | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations